MedPath

Cost-Effectiveness of Sacral Nerve Stimulation by MDT-3110

Not Applicable
Conditions
Chronic fecal incontinence
Registration Number
JPRN-UMIN000006500
Lead Sponsor
Medtronic Japan Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients without chronic fecal incontinence

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incremental cost effectiveness ratio (ICER) per QALYs (Quality-adjusted life-years) gained
Secondary Outcome Measures
NameTimeMethod
i. ICER per symptom free year ii. ICER per symptom improved year
© Copyright 2025. All Rights Reserved by MedPath